Indication of ICV-STZ-induced AD in rodents (mostly rats) comprises several alterations in the brain, including metabolic, neurochemical, cognitive, and behavioral disturbances, increased levels of Aβ and hyperphosphorylated tau, oxidative stress, as well as neuroinflammation [168] (Figure 5). The gene discussed is MAPT; the disease is Alzheimer disease.